Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of focal segmental glomerulosclerosis with CCR2 antagonists

Treatment of focal segmental glomerulosclerosis with CCR2 antagonists

US Patent 11382915 · Granted Jul 12, 2022

Estimated economic value: $22,229,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclic compounds as receptor modulating therapeutics and methods and uses thereo2025
TGF-β inhibitors2025
Method of treating focal segmental glomerulosclerosis2025
Method of treating focal segmental glomerulosclerosis2025
Method of treating focal segmental glomerulosclerosis2025
Substituted-N-heteroaryl compounds and uses thereof2024
2-oxindole compounds2024
Substituted-pyridinyl compounds and uses thereof2024
Benzazole compounds and methods for making and using the compounds2024
Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or2024
IRAK inhibitors and method for making and using2024
Methods of treating solid tumors with CCR2 antagonists2024